Hsuan-ju Yang
Jiayi Shi, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Olaparib enhancing radiosensitization and anti-metastatic effect of oral cancer by targeting IL-17A signal.
Journal: Cancer cell international
Published: June 01, 2024
Epigenetic modification in radiotherapy and immunotherapy for cancers.
Journal: Tzu chi medical journal
Published: January 03, 2024
Association of spironolactone use with risk of urinary tract cancer in the general population: A matched population-based cohort study.
Journal: PloS one
Published: October 20, 2023
Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study.
Journal: Breast cancer research : BCR
Published: June 26, 2023
IRAK2, an Immune and Radiation-Response Gene, Correlates with Advanced Disease Features but Predicts Higher Post-Irradiation Local Control in Non-Metastatic and Resected Oral Cancer Patients.
Journal: International journal of molecular sciences
Published: March 20, 2023
Hazard-based risk grouping effectively stratifying breast cancer patients in post-irradiation long-term heart diseases: a population-based cohort study.
Journal: Frontiers in cardiovascular medicine
Published: June 28, 2022
IRAK2, an IL1R/TLR Immune Mediator, Enhances Radiosensitivity via Modulating Caspase 8/3-Mediated Apoptosis in Oral Squamous Cell Carcinoma.
Journal: Frontiers in oncology
Published: December 29, 2020
Interleukin-17F expression is elevated in hepatitis C patients with fibrosis and hepatocellular carcinoma.
Journal: Infectious agents and cancer
Published: May 03, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026